CME Pushes CFTC to Regulate On-Chain Exchange Hyperliquid Amid Ongoing STP Delays
CME sits 16% above its 52-week low of $257.17.
Summary
CME Group is urging the Commodity Futures Trading Commission (CFTC) to mandate registration and compliance with U.S. customer tracking and trade monitoring rules for Hyperliquid, an on-chain perpetuals exchange. This specific lobbying effort follows earlier reports of CME and ICE advocating for broader CFTC oversight of crypto platforms. Concurrently, CME Group acknowledged ongoing Straight-Through Processing (STP) delays impacting futures and options flows, a continuation of technical issues reported since early May. The push for regulation against a specific competitor like Hyperliquid underscores CME's strategic move to address competition in the crypto derivatives space. While the STP delays are a known operational concern, the targeted regulatory action represents a material development in CME's competitive strategy. Investors should monitor the CFTC's response and further updates on the resolution of the STP delays.
At the time of this announcement, CME was trading at $299.36 on NASDAQ in the Finance sector, with a market capitalization of approximately $108.3B. The 52-week trading range was $257.17 to $329.16. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.